Phase II Randomized Double-Blind Placebo-Controlled Study to Evaluate the Efficacy and Safety of rhuMAb Beta7 in Patients With Moderate to Severe Ulcerative Colitis.

Status: Completed

Phase of Trial: Phase II

Latest Information Update: 06 Dec 2017

Price :

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

01 Nov 2017 Results assessing the effect of Etrolizumab on histologic inflammation in mucosal biopsies from patients of this trial (n=56), presented at the 25th United European Gastroenterology Week
19 Oct 2016 Results (n=112) assessing Madcam-1 levels in serum, presented at the 24th United European Gastroenterology Week
19 Oct 2016 Results (n=98) assessing VCAM-1 and ICAM-1 serum levels and expression, presented at the 24th United European Gastroenterology Week

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com